Patents by Inventor David Goldblum

David Goldblum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of ocular disorders
    Patent number: 6835748
    Abstract: The present invention is in particular related to the use of rivastigmine in the manufacture of a medicament for the treatment of ocular disorders.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: December 28, 2004
    Assignee: Novartis AG
    Inventor: David Goldblum
  • Treatment of ocular disorders
    Publication number: 20030119832
    Abstract: The present invention is in particular related to the use of rivastigmine in the manufacture of a medicament for the treatment of ocular disorders.
    Type: Application
    Filed: January 23, 2003
    Publication date: June 26, 2003
    Inventor: David Goldblum
  • Treatment of ocular disorders
    Patent number: 6534541
    Abstract: The present invention is in particular related to the use of rivastigmine in the manufacture of a medicament for the treatment of ocular disorders.
    Type: Grant
    Filed: October 11, 2000
    Date of Patent: March 18, 2003
    Assignee: Novartis AG
    Inventor: David Goldblum